Copyright
©The Author(s) 2023.
World J Nephrol. May 25, 2023; 12(3): 40-55
Published online May 25, 2023. doi: 10.5527/wjn.v12.i3.40
Published online May 25, 2023. doi: 10.5527/wjn.v12.i3.40
Variables | PAKT, n = 32 | CAKT, n = 272 | P value |
Age in yr, mean ± SD (range) | 31.7 ± 13 (13-60) | 32.1 ± 11.5 (12-66) | 0.677 |
Sex | |||
Men | 22 (68.8) | 213 (78.3) | 0.263 |
Women | 10 (31.2) | 59 (21.7) | |
Primary kidney disease | |||
Glomerulonephritis | 3 (9.4) | 8 (2.9) | < 0.001 |
Hereditary disease | 3 (9.4) | 6 (2.2) | |
Obstructive uropathy | 4 (12.5) | 8 (2.9) | |
Systemic disease | 4 (12.5) | 14 (5.2) | |
Urolithiasis | 3 (9.4) | 7 (2.6) | |
Unknown | 15 (46.9) | 229 (84.2) | |
Number of potential donors1 | |||
Patients presented without donors | 8 (25) | 36 (13.2) | 0.088 |
With one donor | 17 (53.1) | 187 (68.8) | |
With two donors | 4 (12.5) | 40 (14.7) | |
With three donors | 3 (9.4) | 9 (3.3) | |
Donor evaluation | 24 | 236 | |
Patients with evaluated donors | 20 | 194 | |
With accepted donor(s) | 10 (50) | 89 (45.9) | 0.232 |
With one donor excluded | 7 (35) | 75 (38.7) | |
With two donors excluded | 0 (0) | 15 (7.7) | |
With three donors excluded | 1 (5) | 2 (1) | |
With excluded and accepted donors | 2 (10) | 13 (6.7) | |
Number of not evaluated donors per patient | 6 | 56 | |
One donor | 3 (50) | 51 (91.1) | 0.024 |
Two donors | 3 (50) | 4 (7.1) | |
Three donors | 0 (0) | 1 (1.8) | |
Order of the accepted donor | 12 | 102 | |
First | 10 (83.3) | 87 (85.3) | 0.634 |
Second | 1 (8.3) | 11 (10.8) | |
Third | 1 (8.3) | 4 (3.9) | |
Accepted donor age (yr), mean ± SD (range) | 38.1 ± 9 (25-53) | 40.6 ± 10.4 (21-60) | 0.39 |
Patient-donor relatedness degree | |||
First | 5 (41.7) | 55 (53.9) | 0.234 |
Second | 5 (41.7) | 40 (39.2) | |
Third | 1 (8.3) | 6 (5.9) | |
Unrelated | 1 (8.3) | 1 (1) | |
Sex of accepted donors | |||
Women | 7 (58.3) | 66 (64.7) | 0.754 |
Men | 5 (41.7) | 36 (35.3) | |
Accepted donor commitment | |||
Donated | 4 (33.3) | 55 (53.9) | 0.171 |
Regressed | 1 (8.3) | 16 (15.7) | |
Released | 7 (58.3) | 31 (30.4) | |
Number of excluded donors per patient | |||
One donor | 7 (77.8) | 84 (80) | 0.262 |
Two donors | 1 (11.1) | 19 (18.1) | |
Three donors | 1 (11.1) | 2 (1.9) | |
Main causes of donor exclusion | |||
Medical causes | 1 (10) | 51 (51.5) | 0.027 |
Immunologic mismatch | 7 (70) | 34 (34.3) | |
Combined medical and immunologic | 2 (20) | 14 (14.1) | |
Main causes of donor release | 5 | 28 | |
Financial causes | 0 (0) | 3 (10.7) | 0.235 |
Patient death | 0 (0) | 3 (10.7) | |
Patient non-candidacy | 0 (0) | 10 (35.7) | |
Patient regression | 5 (100) | 12 (42.9) | |
Achievement of kidney transplantation | |||
Failed | 25 (78.1) | 191 (70.2) | 0.568 |
Transplanted in our center | 4 (12.5) | 55 (20.2) | |
Transplanted in another center | 3 (9.4) | 26 (9.6) | |
Cause of non-achievement of transplantation in our center | 28 | 191 | |
Donor exclusion | 8 (28.6) | 88 (40.6) | 0.035 |
Donor regression | 1 (3.6) | 16 (7.4) | |
Donor unavailability | 7 (25) | 37 (17.1) | |
Financial causes | 1 (3.6) | 13 (5.6) | |
Patient non-candidacy | 0 (0) | 25 (11.5) | |
Patient death | 0 (0) | 5 (2.6) | |
Patient regression | 11 (39.3) | 33 (15.2) | |
Fate of recipients who failed to have transplantation in our center | |||
Death | 0 (0) | 13 (6) | 0.213 |
On hemodialysis | 24 (85.7) | 147 (67.7) | |
Transplantation in another center | 3 (10.7) | 26 (12) | |
Unknown | 1 (3.6) | 31 (14.3) |
- Citation: Gadelkareem RA, Abdelgawad AM, Reda A, Azoz NM, Zarzour MA, Mohammed N, Hammouda HM, Khalil M. Preemptive living donor kidney transplantation: Access, fate, and review of the status in Egypt. World J Nephrol 2023; 12(3): 40-55
- URL: https://www.wjgnet.com/2220-6124/full/v12/i3/40.htm
- DOI: https://dx.doi.org/10.5527/wjn.v12.i3.40